These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1085 related items for PubMed ID: 12392341
41. Novel approach to the application of botulinum toxin to the flexor digitorum superficialis muscle in acquired brain injury. Munin MC, Navalgund BK, Levitt DA, Breisinger TP, Zafonte RD. Brain Inj; 2004 Apr; 18(4):403-7. PubMed ID: 14742153 [Abstract] [Full Text] [Related]
44. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696 [Abstract] [Full Text] [Related]
45. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study. Lee J, Yang SN. Toxins (Basel); 2024 Apr 19; 16(4):. PubMed ID: 38668622 [Abstract] [Full Text] [Related]
46. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL. Neurorehabil Neural Repair; 2010 Jan 19; 24(1):34-41. PubMed ID: 19729582 [Abstract] [Full Text] [Related]
51. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials. Jia S, Liu Y, Shen L, Liang X, Xu X, Wei Y. J Stroke Cerebrovasc Dis; 2020 Jun 19; 29(6):104682. PubMed ID: 32305277 [Abstract] [Full Text] [Related]
52. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke. Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M, Daniele A, Picelli A, Baricich A, Intiso D, Ranieri M. Drugs; 2019 Feb 19; 79(2):143-160. PubMed ID: 30623347 [Abstract] [Full Text] [Related]
53. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment. Sheean G. Drug Saf; 2006 Feb 19; 29(1):31-48. PubMed ID: 16454533 [Abstract] [Full Text] [Related]
54. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. Eur J Neurol; 2001 Nov 19; 8(6):559-65. PubMed ID: 11784339 [Abstract] [Full Text] [Related]
57. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke. Sun SF, Hsu CW, Hwang CW, Hsu PT, Wang JL, Yang CL. Phys Ther; 2006 Oct 19; 86(10):1387-97. PubMed ID: 17012643 [Abstract] [Full Text] [Related]
59. The Effects of the Biceps Brachii and Brachioradialis on Elbow Flexor Muscle Strength and Spasticity in Stroke Patients. Yu B, Zhang X, Cheng Y, Liu L, YanJiang, Wang J, Lu X. Neural Plast; 2022 Oct 19; 2022():1295908. PubMed ID: 35283993 [Abstract] [Full Text] [Related]
60. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke. Demetrios M, Brand C, Louie J, Khan F. J Rehabil Med; 2016 Apr 28; 48(5):426-34. PubMed ID: 27097568 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]